Could ketamine be a fast-acting lifeline for suicidal teens and young adults?

NCT ID NCT04763343

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether ketamine, given as an IV infusion, can quickly lower severe suicide risk in young people aged 14 to 30 who have just attempted suicide. Participants receive either ketamine or a placebo while in the hospital, plus weekly therapy sessions. The goal is to see if ketamine helps reduce suicidal thoughts faster and keeps patients engaged in follow-up care.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SUICIDE, ATTEMPTED are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Suicide, Attempted

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Massachusetts General Hospital

    RECRUITING

    Boston, Massachusetts, 02115, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • The Cleveland Clinic

    RECRUITING

    Cleveland, Ohio, 44195, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••